have been reported by Gupta and co-workers (15), who found a quantitative association between cigarette smoke and DNA Nasal epithelium is an easily accessible tissue that is adducts in the nasal mucosa of rats. In order to evaluate potentially useful for human biomonitoring studies aimed whether a similar relationship could be found in human nasal at evaluating exposure to airborne carcinogens. We have mucosa, a target tissue of tobacco smoke with a high potential devised a simple technique, which causes minimum distress for human biomonitoring, 21 nasal biopsies from smokers and to the informed patient, to obtain very small but sufficient non-smokers were analyzed to determine the presence of biopsies from the inferior or middle turbinate head. DNA tobacco smoke-associated DNA adducts. adducts were measured by 32 P-postlabeling assay in nasal mucosa of nine cigarette smokers (including two subjects Materials and methods who had given up smoking shortly before sampling), two former smokers and 10 non-smoker healthy donors. None 
Introduction
questionnaire was submitted to each subject at the time of biopsy. Detailed information was collected on demographic data, smoking history, occupation
Cancer of the nasal and paranasal sinuses, albeit a rather and possible exposure to other environmental DNA damaging agents. Two uncommon disease, has a high death rate and causes serious subjects (N8 and N9) who declared they had given up smoking one or a few months before biopsy (respectively) were considered as current smokers. For impairment of the quality of life among survivors (1). Exposure passive smoking it was asked in the questionnaire if the subject was exposed to various carcinogens, especially in the workplace, has been to the smoke produced by smokers, at home or in the workplace. The subject identified as a causative agent (2-4) and among non-occupawas asked to indicate the average length of exposure per day, in hours.
tional factors, cigarette smoking has frequently been investi-DNA hydrolysis and 32 P-postlabeling analysis gated. Significant increases in relative risk for current smokers, Ten micrograms of DNA samples (2 µg/µl) were digested to 3Ј-mononucleoespecially for squamous cell carcinomas, have been reported tides with 0.46 U micrococcal nuclease (0.312 U/µl) and 0.0174 U spleen by various authors (5). Nevertheless, negative reports have phosphodiesterase (0.0058 U/µl) in 17 mM sodium succinate, 8 mM calcium chloride, pH 6.0 (15 µl final reaction volume) at 37°C for 4.5 h. DNA been published as well (6). Over 50 carcinogenic compounds, hydrolysates were evaporated to dryness and redissolved in 6 µl water. The including polycyclic aromatic hydrocarbons (PAHs*), aromatic nuclease P1 version of the 32 P-postlabeling assay was used to analyze for the amines and nitrosamines, are present in tobacco smoke (7) presence of DNA adducts as previously described (16) . Normal nucleotides and many of them are able to form DNA adducts after (10 µg) were dephosphorylated at the 3Ј-position by treatment with 5 µg metabolic activation to electrophilic species (8). The 32 Pnuclease P1 for 40 min at 37°C in 9 µl reaction volume. Two smokers and two non-smoker referent DNA samples (4 µg for each sample) were also postlabeling assay has been widely used to measure the analyzed by the butanol extraction procedure, which involves addition of tetrabutylammonium chloride to the aqueous solutions of the DNA digests followed by extraction of adducts with butanol (17) . The hydrolysates enriched *Abbreviations: PAHs, polycyclic aromatic hydrocarbons; DRZ, diagonal radioactive zone; RAL, relative adduct labeling.
in adducted nucleotides (10.8 µl) were 32 P-labeled at the 5Ј terminus using the two values were in good agreement (r ϭ 0.93), all subsequent statistical analyses were based on the average value. Details of the age, gender, smoking history, occupation and level of DNA adducts from the 21 subjects undergoing nasal mucosa biopsy are shown in Table I . A remarkable difference in the level of DNA adducts depending on smoking habit was found (ANOVA P Ͻ 0.01). When specific smoking categories are compared, the mean level of DNA adducts was significantly higher in current smokers with respect to nonsmokers (P Ͻ 0.001) (Figure 2 ). The association between the level of DNA adducts and smoking history was strengthened by the presence of a signi- between the daily consumption of cigarettes and the level of between the variables taken into consideration and the level Univariate and multivariate statistical analyses were performed using of DNA adducts.
parametric tests on log transformed data. Data were analyzed with the SPSS for Windows statistical package (18) .
DNA adduct profiles and relative adduct labeling (RAL) levels by the butanol extraction method

Results
DNA adduct recovery may vary greatly depending on the DNA adduct profiles by the nuclease P1 technique enhancement technique used. Therefore, the simultaneous use of the nuclease P1 and the butanol extraction methods is useful Figure 1 shows two typical autoradiograms of two chromatoto examine the adduct formation of unknown structures and grams of 32 P-postlabeled digests of nasal DNA from a smoker to determine the most appropriate enrichment protocol (19) . ( Figure 1A ) and from a non-smoker referent ( Figure 1B )
The nuclease P1 technique alone is able to detect bulky respectively. The autoradiographic findings revealed the preshydrophobic adducts, such as those formed by the PAHs and ence of a diagonal radioactive zone (DRZ) in eight out of nine some arylamines bound to the exocyclic position of guanine smoker samples analyzed and in one referent out of 10 samples or adenine (19) , while extraction with butanol is effective for ( Table I ). The intensity of the radioactive diagonal was strong most aromatic amines bound to the C-8 position of guanine and in most autoradiographs, except in the case of smoker N6, some low molecular weight alkylating agents (19) . Moreover, a where a faint DRZ and two adduct spots close to the radioactive similar DNA adduct recovery has been shown for some PAH zone were detected, and in the case of smoker N5, where no adducts using both the nuclease P1 and the butanol extraction DRZ and one adduct spot was found in the right part of the techniques (19) . Therefore, we decided to analyze the nasal chromatogram.
DNA samples from two smokers and from two non-smoker Concerning the two subjects who stopped smoking immedireferents using not only the nuclease P1 technique but also ately before the biopsy, a strong DRZ and a spot migrating to the butanol extraction method, in order to compare the behavior the right of the zone were detected in sample N8, while a of the two approaches. Because the nuclease P1 analysis had fainter DRZ and two faint adduct spots, close to the radioactive already been performed, we selected two typical samples (N2 diagonal, were present in the chromatogram of sample N9. A and N4) for smokers and two typical samples (N13 and weak DRZ and two adduct spots were found in the central N19) for non-smokers (Table I) . Both techniques showed the part of the chromatogram of the former smoker N11, who had presence of a strong DRZ in the two smoker DNA samples given up 13 years before the biopsy. No DRZ and three spots (Figures 1 and 4) . The two referents (N13 and N19), negative were detected in the central part of the TLC plate of the former for the DRZ but showing one or two weak spots respectively smoker N10, who had stopped smoking 16 years earlier. The (average RAL values 1.07 and 1.35 ϫ 10 Ϫ8 respectively) using autoradiograms of non-smoker samples showed essentially the nuclease P1 method, were practically completely negative only a rather weak radioactive spot (different from sample to using the butanol extraction method (RAL values 0.1 and sample), except in the case of non-smoker referents N14 and 0.32 ϫ 10 Ϫ8 respectively; Figure 4 and Table I ). N15, where a DRZ and three central adduct spots were revealed respectively. Discussion DNA adduct levels by the nuclease P1 technique The 32 P-postlabeling analysis was performed in duplicate and Our findings show that smokers have higher levels of DNA adducts in nasal mucosa ( Figure 2 and Table I ) and that a the results of the two analyses are reported in Table I . Because qualitatively (DRZ) or quantitatively (24) . The similarity between our chromatographic findings and those seen in human lung suggests that the metabolic activation of cigarette carcinogens in nasal mucosa could be similar to that occurring in the lower respiratory tract (22) (even though the histological type of the the two tissues is different; 25,26). Another major result of this study is the significant association between DNA adduct levels and the number of cigarettes smoked daily, as revealed in the nasal tissue of smokers ( Figure 3 and Table I ). A similar correlation between cigarette consumption and adduct levels has already been reported in the lung tissue of smokers (20, 21) . The existence of a direct relationship between daily cigarette consumption and adduct levels indicates that the genotoxic action of tobacco smoke is as critical in nasal mucosa tissue as it is in lung tissue. The low level of DNA adducts in smoker N5 (Table I ) might be due to some misclassification in smoking status, since the smoking history was self-reported by questionnaire and no independent measure of smoking, such as urine cotinine, was carried out. Similarly, two subjects in the non-smoker naire. In this case, both subjects were exposed for many hours to passive smoke (Table I) . Differences between individuals in the metabolism of carcinogens (27) or in the rate of DNA repair could also have affected the levels of adducts measured.
The results obtained using nasal mucosa were compared with those reported by four selected studies of bronchi and lung tissues of smokers and non-smokers using the nuclease P1 technique (Table II; 20, 23, 28, 29) . Although the absolute level of DNA adducts in nasal mucosa was slightly lower, the similarity of the mean ratios in the tissues considered indicates a similar capability to differentiate adduct formation between smokers and non-smokers using the nuclease P1 technique (Table II) .
For oral mucosa we are aware of three reports (12-14). In the first two papers (12,13) no clear-cut difference was observed habit was reported in the third paper (14) . Our findings are apparently in contrast to those of this third report, where the presence of DNA adducts was essentially associated with specific spot pattern, the DRZ, is present in their chromatograms ( Figure 1 and Table I ). A similar chromatographic aromatic amines and nitroaromatics rather than with PAHs contained in the cigarette smoke. In order to better compare pattern has already been described in human lung and in other tissues of cigarette smokers, such as bronchus, heart, kidney, our results with the results of this study on oral mucosa (14), we applied both the nuclease P1 and the butanol extraction placenta and ascending aorta, using the nuclease P1 enrichment procedure (20, 21) . This adduct pattern broadly reflects the enhancement techniques to four selected samples (Table II) . The data reported in Table II show that the ratio of mean polycyclic aromatic compounds present in tobacco smoke and indicates that DNA adducts are primarily formed by a complex adduct levels, which expresses the capability to differentiate between smokers and non-smokers, is higher using nasal tissue mixture of these chemicals (20, 21) . The similarity, both qualitative and quantitative, of the DNA adduct profiles of smoker and that the DNA adduct levels are contained within a relatively narrow range in the case of lung, bronchial, nasal and oral samples obtained using the nuclease P1 and the butanol extraction procedures (Figures 1 and 4 and Table I) indicates mucosa tissues using the nuclease P1 technique (range of RAL ϭ 4.1-11.3 ϫ 10 Ϫ8 for smokers), while they are much that the adducts detected in the nasal DNA may derive primarily from PAHs and not from aromatic amines (19) . This higher in the case of oral mucosa using the butanol extraction method (RAL ϭ 37 ϫ 10 Ϫ8 ). The different adduct recoveries result is in agreement with the fact that most of the DNA damage detected in the lung, bronchus and larynx of cigarette determined in oral tissue of smokers using the two enhancement techniques (14) is apparently in contrast to our results, with smokers seems to be due to PAH adducts, rather than to aromatic amine adducts (20, (22) (23) (24) . The same kind of DNA those reported by Phillips et al. (23) and with the results of an Interlaboratory Trial (24) , which have shown the nuclease adduct recovery determined in nasal mucosa DNA of smokers has already been shown in human bronchial DNA of smokers, P1 and the butanol extraction enhancement methods to have similar DNA adduct recoveries, both qualitatively and quantitwhere no difference between the use of the nuclease P1 and butanol extraction enhancement methods was obtained, either atively, in the case of lung, bronchus and nasal tissue (this report) of smokers. We can hazard two types of explanation for Our results indicate that the nasal mucosa may be efficiently used as a target tissue to study tobacco-associated DNA this discrepancy: (i) unexplained methodological differences in the butanol extraction technique applied in the different adducts. In summary, these preliminary findings suggest that the level of DNA adducts measured from biopsies of the nasal laboratories [which could also explain the very high DNA adduct levels observed by Johns et al. (14) in non-smoker mucosa is a reliable marker of exposure to carcinogens contained in cigarette smoke and uphold its use in the biomonisubjects] (Table 2) ; (ii) an important difference in the metabolic activation of carcinogens by oral mucosa compared with lung, toring of humans exposed to airborne pollution or at higher risk of nasal cancer. bronchus and nasal tissues, such that the butanol extraction method reveals many more adducts in oral mucosa, perhaps linked to aromatic and nitroaromatic compounds, as suggested Acknowledgements by Johns et al. (14) . 
